DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Hydroxyethyl cellulose is an investigational drug.
There have been 4 clinical trials for Hydroxyethyl cellulose. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2012.
The most common disease conditions in clinical trials are Vaginosis, Bacterial, Vaginal Diseases, and Vaginitis. The leading clinical trial sponsors are CONRAD, Starpharma Pty Ltd, and National Institutes of Health (NIH).
There are two US patents protecting this investigational drug and twenty international patents.
Recent Clinical Trials for Hydroxyethyl cellulose
|A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04||National Institute of Allergy and Infectious Diseases (NIAID)||Phase 1|
|A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04||National Institutes of Health (NIH)||Phase 1|
|A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04||CONRAD||Phase 1|
Top disease conditions for Hydroxyethyl cellulose
Top clinical trial sponsors for Hydroxyethyl cellulose
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Hydroxyethyl cellulose||Start Trial||Rubbers with tunable levels of metal containing anti-agglomerants||ARLANXEO Singapore Pte. Ltd. (Singapore, SG)||Start Trial|
|Hydroxyethyl cellulose||Start Trial||Printing ink dispersions comprising discrete carbon nanotubes||Molecular rebar Design, LLC (Austin, TX)||Start Trial|
|Hydroxyethyl cellulose||Start Trial||Protective flowable or spreadable composition, articles of manufacture, an apparatus for manufacture and a process for manufacture thereof||Start Trial|
|Hydroxyethyl cellulose||Start Trial||Fracturing or gravel-packing fluid with CMHEC in brine||Halliburton Energy Services, Inc. (Houston, TX)||Start Trial|
|Hydroxyethyl cellulose||Start Trial||Composition of redox-reagents for electrochemical biosensor and biosensor comprising the same||I-SENS, INC. (Seoul, KR)||Start Trial|
|Hydroxyethyl cellulose||Start Trial||Compositions and methods for the treatment of intraocular neovascularization and/or leakage||Retinal Therapies, LLC (Coronado, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Hydroxyethyl cellulose||Canada||2934807||2033-12-23||Start Trial|
|Hydroxyethyl cellulose||China||106232709||2033-12-23||Start Trial|
|Hydroxyethyl cellulose||European Patent Office||3087138||2033-12-23||Start Trial|
|Hydroxyethyl cellulose||Japan||2017502152||2033-12-23||Start Trial|
|Hydroxyethyl cellulose||Japan||6523297||2033-12-23||Start Trial|
|Hydroxyethyl cellulose||South Korea||20160115921||2033-12-23||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|